Half Year 2025 Glanbia PLC Earnings Call Transcript

Aug 13, 2025 / 07:30AM GMT
Release Date Price: $71

Key Points

Positve
  • Glanbia PLC (GLAPF) reported a resilient performance with adjusted earnings per share of $0.6303, driven by strong growth in Health and Nutrition and Dairy Nutrition divisions.
  • The company delivered revenues of $1.9 billion, representing an increase of 6% on a constant currency basis.
  • Health and Nutrition division saw like-for-like revenue growth of 6.5% with volume growth of 6.9%, driven by Nutritional premix and Flavor Solutions businesses.
  • Dairy Nutrition experienced strong growth in Protein Solutions and favorable pricing due to strong whey protein demand.
  • Glanbia PLC (GLAPF) raised the interim dividend by 10% and returned approximately EUR63 million to shareholders via share buyback programs.
Negative
  • Performance Nutrition division faced a decline with like-for-like revenue down 3.8%, driven by a decrease in volume and price.
  • Group EBITDA pre-exceptional decreased by 7.5% with EBITDA margins declining by 180 basis points due to elevated whey protein costs.
  • The company incurred exceptional items net of tax of $32.6 million, primarily related to the group-wide transformation program.
  • Net finance costs increased by $3.2 million compared to the prior year due to higher average net debt.
  • Performance Nutrition Americas, representing 61% of revenue, was down 8.7% versus last year due to headwinds in the US, club, and specialty channels.
Operator

Good day, and thank you for standing by. Welcome to the Glanbia 2025 half year results presentation.(Operator Instructions) Please be advised that today's conference is being recorded.

I will now hand over to Liam Hennigan, Group Secretary and Head of Investor Relations to open the presentation. Please go ahead.

Liam Hennigan
Glanbia PLC - Group Secretary, Head of Investor Relations

Thank you. Good morning, and welcome to the Glanbia 2025 half year results call. During today's call, the directors may make forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval that any a half year 2025 results announcement.

Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The Directors undertake no obligation to update any forward-looking statements made on today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot